SCHEMBL10296013

SCHEMBL10296013

Cc1cc(C)cc(N(C)c2c(C)cccc2C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
TSPO P30536 1/20 0.36
EGFR P00533 2/20 0.35
CSF1R P07333 2/20 0.35
CYP1A2 P05177 3/20 0.33
CYP2A6 P11509 2/20 0.33
RAPGEF4 Q8WZA2 2/20 0.33
AR P10275 1/20 0.33
HDAC6 Q9UBN7 2/20 0.33
ALDH1A1 P00352 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
TSHR P16473 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
NSD2 O96028 1/20 0.32
CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22336609 0.86 AR (0.37) TSPOCYP1A2CYP2A6RAPGEF4AR
SCHEMBL16264001 0.84 RAPGEF4 (0.41) ACHECYP1A2CYP2A6RAPGEF4ALDH1A1
SCHEMBL22337431 0.81 CSF1R (0.47) ACHEEGFRCSF1RALDH1A1TSHR
SCHEMBL22336611 0.80 ALDH1A1 (0.48) ACHECYP1A2CYP2A6HDAC6ALDH1A1
SCHEMBL15362296 0.77 TSHR (0.41) ACHEEGFRCYP1A2CYP2A6ALDH1A1
SCHEMBL13367388 0.77 TSPO (0.39) ACHETSPOCYP1A2CYP2A6TSHR
SCHEMBL13367407 0.76 ACHE (0.55) ACHEEGFRCSF1RALDH1A1TSHR
SCHEMBL18719354 0.76 CYP1A2 (0.40) ACHEEGFRCYP1A2CYP2A6CA9
SCHEMBL13509012 0.75 TSHR (0.42) ACHETSPORAPGEF4ARALDH1A1
SCHEMBL26996636 0.74 AR (0.38) ACHETSPOCYP1A2CYP2A6RAPGEF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020162600-A1 POLYCYCLIC AROMATIC COMPOUND 学校法人関西学院 2020-08-13 WO disclosed
US-8212056-B2 Ligands for transition-metals and methods of use THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2012-07-03 US disclosed
US-8212056-B2 Ligands for transition-metals and methods of use THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2012-07-03 US disclosed
US-20090326243-A1 Ligands for transition-metals and methods of use THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2009-12-31 US disclosed
US-20090326243-A1 Ligands for transition-metals and methods of use THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326243-A1 Ligands for transition-metals and methods of use PDK4, PDXK, PDK3 ACHE 236/4885TSPO 884/4885EGFR 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.